US PTAB IP Litigation

Amazon.com, Inc. et al. v.Nokia Technologies Oy

· IPR2024-00920

Amazon’s request to overturn Nokia’s video‑compression patent was denied after the Board found the petitioners’ claim constructions erroneous and unsupported by expert testimony.

Abbott Diabetes Care Inc. et al. v.DexCom, Inc.

· IPR2024-00891

Abbott Diabetes Care and DexCom have entered a confidential settlement and jointly moved to terminate IPR2024-00891 covering U.S. Patent No. 11,020,031. The motion cites 35 U.S.C. §317(a) and notes that the Board has not yet decided the merits. The parties also seek termination of related IPRs and a district‑court case.

Abbott Diabetes Care Inc. et al. v.DexCom, Inc.

· IPR2024-00891

Abbott Diabetes Care and DexCom have jointly filed a request with the PTAB to keep their settlement agreement confidential, invoking statutory provisions for business‑confidential treatment.

smaXtec Inc. et al. v.ST Reproductive Technologies, LLC et al.

· IPR2024-00885

In its preliminary reply, the patent owner defends the 8,823,515 patent against smaXtec's IPR petition by asserting that the Trevarthen reference was publicly accessible before the critical date and that the Laitinen disclosure satisfies the ‘implanted’ claim language.

Abbott Diabetes Care Inc. et al. v.DexCom, Inc.

· IPR2024-00890

Abbott Diabetes Care and DexCom have jointly moved to terminate IPR2024-00890 after reaching a confidential settlement and license agreement, invoking 35 U.S.C. § 317(a). The Board has not yet decided the merits, and the parties argue good cause for termination.

Abbott Diabetes Care Inc. et al. v.DexCom, Inc.

· IPR2024-00841

Abbott Diabetes Care and DexCom have entered into a settlement and jointly moved to terminate the inter partes review covering DexCom’s continuous glucose monitoring patent (U.S. 10,709,364). The Board has not yet decided the merits, satisfying the statutory requirements for termination under 35 U.S.C. §317(a).

WIZ, Inc. v.Orca Security Ltd.

· IPR2024-00865

Orca Security filed a Request for Director Review challenging the PTAB’s Final Written Decision that found all claims of its cloud‑virtualization patent unpatentable. The owner contends the Board improperly introduced new evidence—misinterpreting Veselov’s description of a file system—as teaching the claimed virtual‑disk location, violating procedural rules.

Samsung Electronics Co., Ltd. et al. v.Empire Technology Development LLC

· IPR2024-00896

Samsung has filed a preliminary reply opposing Empire Technology’s narrow claim construction of “idle power consumption” in U.S. Patent 8,798,120. The argument centers on the patent’s disclosure of leakage‑current power draw during sleep mode, which Samsung says renders the proposed construction unsupported.

Abbott Diabetes Care Inc. et al. v.DexCom, Inc.

· IPR2024-00840

Abbott Diabetes Care and DexCom have filed a joint request to keep their settlement agreement confidential, invoking statutory provisions that allow business‑confidential treatment of settlement documents.

Zepp Health Corporation v.Slyde Analytics, LLC

· IPR2024-00833

Zepp Health and Slyde Analytics filed a joint motion to terminate their IPR after reaching a settlement, which the Board approved and treated the settlement as confidential business information.

Abbott Diabetes Care Inc. et al. v.DexCom, Inc.

· IPR2024-00840

Abbott Diabetes Care and DexCom have entered into a confidential settlement and license agreement and jointly moved to terminate IPR2024-00840 under 35 U.S.C. §317(a). The Board has not yet decided the merits, satisfying the statutory criteria for termination.

Texas Instruments Incorporated v.ParkerVision, Inc.

· IPR2024-00934

An email notifies the parties that ParkerVision’s Director Review request in IPR2024‑00934 has been received, allowing Texas Instruments a 15‑page response.

fuboTV Media Inc. et al. v.DISH Technologies L.L.C. et al.

· IPR2024-00918

A joint notice was filed by DISH Technologies and the petitioners confirming that the Final Written Decision in IPR2024-00918 contains no confidential information, allowing it to be publicly released.

Godbersen-Smith Construction Company d/b/a GOMACO Corporation v.Guntert & Zimmerman Const. Div., Inc.

The USPTO denied GOMACO's request for Director Review of the Final Written Decision in IPR2024-00835, leaving the prior Board decision in place.

WIZ, Inc. v.Orca Security Ltd.

· IPR2024-00865

The PTAB issued an errata to correct a grammatical mistake in the Final Written Decision of IPR2024-00865 concerning patent 11,693,685. The correction clarifies the Board’s language about Hufsmith’s teaching on detecting sensitive data.

WIZ, Inc. v.Orca Security Ltd.

· IPR2024-00865

The USPTO denied director review petitions for two IPRs involving WIZ, Inc. and Orca Security Ltd., leaving the final written decisions unchanged.

smaXtec Inc. et al. v.ST Reproductive Technologies, LLC et al.

· IPR2024-00875

smaXtec challenges ST Reproductive Technologies’ animal‑implant RFID patent, arguing the prior art was publicly accessible before the critical date and that the Laitinen disclosure anticipates the claimed implanted device elements.

Pharaoh Energy Services, LLC v.Flex-Chem Holding Company, LLC et al.

· IPR2024-00822

Pharaoh Energy Services has filed an IPR petition seeking to invalidate Flex‑Chem’s 9,944,843 well‑stimulation patent. The petition relies on Frenier and Reyes as prior art to argue anticipation and obviousness of all 13 claims. The Board has yet to decide whether to institute the review.

Godbersen-Smith Construction Company d/b/a GOMACO Corporation v.Guntert & Zimmerman Const. Div., Inc.

Gomaco urges the PTAB Director to deny G&Z’s review request, arguing that the Board’s obviousness finding for the ’318 slipform paver patent is fully supported by the CIII and Rio prior art. The petitioner contends no claim construction is needed and that the Board’s reasoning is adequate.

Ericsson Inc. et al. v.Active Wireless Technologies LLC

· IPR2024-00986

Ericsson and Nokia settled their IPR disputes with Active Wireless Technologies, leading the PTAB to terminate the three pending reviews and keep the settlement agreements confidential.

Abbott Diabetes Care Inc. et al. v.DexCom, Inc.

· IPR2024-00861

Abbott Diabetes Care and DexCom settled their IPR dispute over U.S. Patent 9,801,541, filing a joint motion that led the PTAB to terminate the proceeding and keep the settlement agreement confidential.

Godbersen-Smith Construction Company d/b/a GOMACO Corporation v.Guntert & Zimmerman Const. Div., Inc.

GOMACO challenges the PTAB’s decision on a slipform paver patent, asserting the Board failed to resolve a key claim‑construction issue and erred in its obviousness and copying analyses. The patent owner seeks Director Review to vacate the decision.

Godbersen-Smith Construction Company d/b/a GOMACO Corporation v.Guntert & Zimmerman Const. Div., Inc.

The USPTO denied GOMACO's request for Director Review of the institution decision in IPR2024-00835, leaving the institution in place.

Godbersen-Smith Construction Company d/b/a GOMACO Corporation v.Guntert & Zimmerman Const. Div., Inc.